Skip to main content

TRAIL

  • 1st Edition, Volume 67 - February 2, 2012
  • Latest edition
  • Editor: Gerald Litwack
  • Language: English
  • Paperback ISBN:
    9 7 8 - 0 - 1 2 - 4 1 1 3 3 2 - 9
  • eBook ISBN:
    9 7 8 - 0 - 0 8 - 0 5 2 2 8 7 - 6

The discovery of TRAIL (TNF Related Apoptosis Inducing Ligand), also referred to as Apo-2, is in an era of intense research because TRAIL induces many cancer cells to undergo… Read more

BACK-TO-SCHOOL

Fuel your confidence!

Up to 25% off learning resources

Elsevier academics book covers
The discovery of TRAIL (TNF Related Apoptosis Inducing Ligand), also referred to as Apo-2, is in an era of intense research because TRAIL induces many cancer cells to undergo programmed cell death (apoptosis), while having no effect on normal cells. This important protein deserves extensive review at a formative time in the devlopement of our knowledge concerning its mechanism of action and the ways in which it can be used as a cancer chemotherapeutic agent. Consequently, this voume reviews the current status of research on TRAIL.

Related books